It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

BioNTech

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Pfizer and BioNTech launch trial of omicron-targeted COVID-19 vaccine

World Jan 26, 2022

Pfizer and BioNTech launch trial of omicron-targeted COVID-19 vaccine

The companies plan to test the immune response generated by the omicron-based vaccine both as a three-shot regimen in unvaccinated people and as a booster shot.

Pfizer starts making vaccine that targets both omicron and the original COVID virus

World / Science & Health Jan 11, 2022

Pfizer starts making vaccine that targets both omicron and the original COVID virus

by Riley Griffin

While research continues, Pfizer will evaluate the new hybrid shot against one specific to omicron and determine which should move forward by March, the firm's CEO has said.

What’s worst about omicron so far is the uncertainty

Commentary / World Dec 1, 2021

What’s worst about omicron so far is the uncertainty

by Andreas Kluth

How should the world respond to omicron? We just have to wait as there is information that we don’t yet have. And for many, the waiting itself is the problem.

Pfizer submits COVID-19 vaccine data to U.S. regulators for use in younger kids

World Sep 29, 2021

Pfizer submits COVID-19 vaccine data to U.S. regulators for use in younger kids

A Pfizer spokesperson said the company expects to start and complete its application very soon.

BioNTech vaccines finally reach Taiwan after heated political wrangling

Asia Pacific Sep 2, 2021

BioNTech vaccines finally reach Taiwan after heated political wrangling

by Ann Wang

Taiwan has blamed China, which claims the island as its own territory, for nixing an original order from the German firm earlier this year.

Taiwan says China blocked deal with BioNTech for COVID-19 shots

Asia Pacific May 26, 2021

Taiwan says China blocked deal with BioNTech for COVID-19 shots

While Taiwan has previously said it had been unable to sign a final contract with BioNTech, it had only implied that Chinese pressure was to blame.

Pfizer and Moderna vaccines highly effective after first shot in real-world use, study finds

World Mar 30, 2021

Pfizer and Moderna vaccines highly effective after first shot in real-world use, study finds

The results validate earlier studies that had indicated the vaccines begin to work soon after a first dose, and confirm that they also prevent asymptomatic infections.

Hong Kong offers a masterclass in vaccine confusion

Commentary / World Mar 26, 2021

Hong Kong offers a masterclass in vaccine confusion

by Clara Ferreira Marques

Hong Kong was always going to struggle to run a mass vaccination campaign.

Pfizer-BioNTech shot could help end pandemic, Israel study shows

World Feb 25, 2021

Pfizer-BioNTech shot could help end pandemic, Israel study shows

It was the largest study yet to quantify the impact of the vaccine outside the rigorous confines of a randomized, blinded clinical trial aimed at measuring effectiveness for regulators.

Pfizer-BioNTech shot stops COVID-19 spread, Israeli study shows

World Feb 22, 2021

Pfizer-BioNTech shot stops COVID-19 spread, Israeli study shows

by Naomi Kresge and Jason Gale

The study provides the first real-world indication that the immunization will curb transmission of the coronavirus, but experts cautioned that more data is needed.

Japan prepares to dispense Pfizer vaccine from Wednesday after formal approval

National / Science & Health Feb 15, 2021

Japan prepares to dispense Pfizer vaccine from Wednesday after formal approval

by Osamu Tsukimori

Up to 20,000 front-line medical staffers at state-run hospitals are set to be the first to receive the vaccines, followed by 3.7 million other health care workers.

Spread of variants sparks push for all-in-one COVID-19 vaccines

World / Science & Health Feb 14, 2021

Spread of variants sparks push for all-in-one COVID-19 vaccines

by James Paton and Suzi Ring

Dangerous coronavirus variants are carpeting the globe, pushing scientists in the U.K. and elsewhere to target multiple versions of the pathogen in a single shot.

VIEW OLDER ARTICLES

  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times